Citation: Hl. Jenkins et Ca. Spencer, RNA polymerase II holoenzyme modifications accompany transcription reprogramming in herpes simplex virus type 1-infected cells, J VIROLOGY, 75(20), 2001, pp. 9872-9884
Citation: Ca. Spencer et al., Mitotic transcription repression in vivo in the absence of nucleosomal chromatin condensation, J CELL BIOL, 150(1), 2000, pp. 13-26
Authors:
Spencer, CA
LoPresti, JS
Fatemi, S
Nicoloff, JT
Citation: Ca. Spencer et al., Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement, THYROID, 9(5), 1999, pp. 435-441
Authors:
Galloway, AM
Spencer, CA
Anderson, CW
Allalunis-Turner, MJ
Citation: Am. Galloway et al., Differential stability of the DNA-activated protein kinase catalytic subunit mRNA in human glioma cells, ONCOGENE, 18(6), 1999, pp. 1361-1368
Authors:
Long, MC
Leong, V
Schaffer, PA
Spencer, CA
Rice, SA
Citation: Mc. Long et al., ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II, J VIROLOGY, 73(7), 1999, pp. 5593-5604
Authors:
Haugen, BR
Pacini, F
Reiners, C
Schlumberger, M
Ladenson, PW
Sherman, SI
Cooper, DS
Graham, KE
Braverman, LE
Skarulis, MC
Davies, TF
DeGroot, LJ
Mazzaferri, EL
Daniels, GH
Ross, DS
Luster, M
Samuels, MH
Becker, DV
Maxon, HR
Cavalieri, RR
Spencer, CA
McEllin, K
Weintraub, BD
Ridgway, EC
Citation: Br. Haugen et al., A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer, J CLIN END, 84(11), 1999, pp. 3877-3885